D. Pecek1, K.A. Sime1, V.E. Ronaldson1, S.M. Connolly1, L.A. Hodges1, F.J. McInnes2 and H.N.E. Stevens1,2
1Bio-Images Research Ltd, Glasgow, G4 0SF, UK; 2Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, G4 0NR, UK
Following extensive in vitro
characterization of a novel targeting delivery device, a clinical study was conducted in healthy volunteers to evaluate the in vivo
behavior of this system.